The alternative investment arm of Motilal Oswal Financial Services Ltd has acquired a majority stake in export-focused bulk drug maker Megafine Pharma Ltd for ₹460 crore, betting on its growth ...

Motilal Oswal Financial Services Limited (NSEI:MOTILALOFS) is currently trading at a trailing P/E of 30.4x, which is higher than the industry average of 24x. While MOTILALOFS might seem like a ...

Motilal Oswal Private Equity (MOPE) will invest up to ₹194.4 crore ($25 million) in Mankind Pharma’s diagnostics venture Pathkind from its fourth fund, it said on Friday. The investment from ...

The ‘arc of essence’ in the logo has been retained to indicate the brand’s focus on providing research-based insights and advice to its serious investor customers. Motilal Oswal, group managing ...

The PE firm is estimated to have put in around Rs 65 crore in total in tranches in the public listed company, as per VCCircle estimates. In March last year, Motilal Oswal PE had invested around Rs ...